Results 271 to 280 of about 24,552 (280)

BTK inhibitors: past, present, and future

Trends in Pharmacological Sciences
Skye Montoya, Justin Taylor
exaly  

The effect of Bruton's tyrosine kinase (BTK) inhibitors on collagen‐induced platelet aggregation, BTK, and tyrosine kinase expressed in hepatocellular carcinoma (TEC)

European Journal of Haematology, 2018
Taisei Kinoshita, Juthamas Sukbuntherng, Danelle James   +2 more
exaly  

Outmaneuvering BTK

C&EN Global Enterprise
openaire   +1 more source

Unusual Mutations in Btk: An Insertion, a Duplication, an Inversion, and Four Large Deletions

Clinical Immunology, 1999
Jürg Rohrer, Y Minegishi, Darko Richter   +2 more
exaly  

8E5A10, anti-BTK

Hybridoma, 1995
openaire   +1 more source

Discovery of a novel BTK inhibitor S-016 and identification of a new strategy for the treatment of lymphomas including BTK inhibitor-resistant lymphomas

Acta Pharmacologica Sinica
Lin-Jiang Tong, Hua Xie
exaly  

Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia

Nature Reviews Clinical Oncology
Michele Stanchina, Skye Montoya, Juan Pablo Alderuccio   +2 more
exaly  

Evolution of BTK inhibitors

Lynchburg Journal of Medical Science
openaire   +1 more source

BTK Degradation Overcomes Recurrent BTK Mutations in B-Cell Malignancies

Cancer Discovery
openaire   +1 more source

Btk inhibitors toxicities

2019
openaire   +1 more source